#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uveal melanoma Synovial sarcoma recurrent Essential thrombocythaemia Epstein-Barr virus associated lymphoproliferative disorder Malignant central nervous system neoplasm Anti-myelin-associated glycoprotein antibodies positive Chondrosarcoma Selective polysaccharide antibody deficiency Atopic keratoconjunctivitis Thrombotic thrombocytopenic purpura Encephalitis autoimmune Hyperinsulinaemic hypoglycaemia Plasma cell myeloma Rett syndrome Hereditary angioedema More trials…

    Learn about Rare Diseases

    Lymphangioma Pituitary-dependent Cushing’s syndrome – Life with Disease Pleomorphic leiomyosarcoma – Treatment Pulmonary fibrosis Lennox-Gastaut syndrome – Trials in Disease VEXAS syndrome – Diagnostics Choroid melanoma – Diagnostics Haemophilia A with anti factor VIII – Life with Disease Marfan’s syndrome – Diagnostics Myxofibrosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pristinamycin IMEROPRUBART LIGUFALIMAB Tasipimidine Propranolol Nystatin Bosutinib Bendamustine Hydrochloride Clofutriben Adg126 Quercetin Tasimelteon Quinapril Hydrochloride Empasiprubart Tas3351 Regn7075 VANDETANIB Enfuvirtide Spiramycin Etavopivat More therapies…

    Learn about Your Condition

    Cleft lip and palate Anal incontinence Lichen planus EGFR gene mutation Hypogonadism male Gaucher's disease type I Cardiac failure chronic Cholangiosarcoma Craniotomy Neurotrophic keratopathy Craniosynostosis Coronary artery bypass Cardiac sarcoidosis Diabetic foot Rett syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of High-Dose Vitamin C (Ascorbic Acid) Compared to Placebo in Patients with Sepsis and Acute Respiratory Distress Syndrome (ARDS) in Intensive Care

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Sodium Ascorbate
    • Sodium Chloride
    France

  • Study on the Effects of Aspirin and Omeprazole in Obese and Non-Obese Patients with Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Spain

  • Study of Obinutuzumab and Mycophenolate Mofetil Without Oral Corticosteroids for Treatment of Lupus Nephritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Azathioprine
    • Mycophenolate Mofetil
    France

  • Study on the Effect of Ropivacaine Hydrochloride and Sodium Chloride on Recovery After Inguinal Hernia Surgery for Patients Undergoing Open Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Inguinal hernia
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride
    Finland

  • Study on the Effects of 7% Hypertonic Saline Inhalation and ELTGOL Physiotherapy for Patients with Bronchiectasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Mannitol
    • Sodium Chloride Ph. Eur.
    Spain

  • Study of Nivolumab and Chemotherapy Combination for Patients with Refractory Hodgkin’s Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease refractory
    Investigated Drugs:
    • Nivolumab
    Poland
Previous Page
1 … 405 406 407 408 409 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!